Vivalis is a daily men's capsule ($69/$59/$49, consistent 60-day guarantee) with a published 838 mg proprietary blend — tribulus, horny goat weed, tongkat ali, panax ginseng, ashwagandha, and yohimbe — and no per-ingredient doses. Yohimbe is the review: it's the rare supplement botanical with genuinely drug-like activity (an alpha-2 antagonist once prescribed for ED), documented blood-pressure, heart-rate and anxiety effects, and repeated FDA analyses showing wildly variable yohimbine content in supplements. An unstated dose of it inside a blend is unscreenable by you, your pharmacist, or your cardiologist. Satellite pages drift to other rosters, and an unrelated Walmart product shares the name. Evidence rating: 1.5/5. Product Fit Score: 3.0/5. Men wanting yohimbine's actual file should know it exists as a prescribed, dosed drug in some countries — which is exactly the level of supervision this ingredient warrants.
Vivalis
- Form
- capsule
- Price
- $69 (1 bottle) · $59/bottle (3) · $49/bottle (6)
- Guarantee
- 60-day money-back (stated by seller)
- Sold via
- maxweb
- Label amounts
- Published Supplement Facts panel (per a consumer report): 838 mg six-botanical proprietary blend including YOHIMBE at an undisclosed dose — the queue's most safety-relevant undosed inclusion (FDA-documented cardiovascular/anxiety effects); satellite pages attribute drifting alternate rosters (arginine/maca, fennel/saw-palmetto prostate version, grape seed); a Walmart 'S.O LABS Vivalis for Men' is a different product sharing the name; 60-day guarantee consistent; one page claims 'FDA-approved'
✓ 60-day refund window stated by seller — long enough to run an honest self-trial
Check current price on the seller's site
Affiliate link. Prices and guarantee as shown on the seller's page on 3 September 2026; they may have changed. Not independently verified beyond that page.
Evidence & product fit
| Product Fit factor | Score (out of 5) | Why |
|---|---|---|
| Formula completeness | 2.0 | A published panel with botanical names — credit the disclosure — undone by no per-ingredient doses where one ingredient makes doses safety information, drifting alternate rosters on satellite pages (a fennel/saw-palmetto "prostate" version, an arginine/maca version), an unrelated Walmart product sharing the name, and one page claiming FDA approval. |
| Ease of use | 4.5 | The capsule format is generally straightforward, but clear serving directions were not available in the product facts we verified. |
| Guarantee & buying terms | 3.5 | 60 days, consistently stated, empty bottles accepted. |
| Price / value | 1.5 | $49–69 for an undosed blend whose active question mark is free to avoid. |
| Category relevance | 3.5 | Parts of the named formula are aligned with men's health positioning. Category relevance measures fit to the intended use; it does not mean the finished product has been clinically proven effective. |
Might suit you if…
- Effectively no one as sold — the yohimbe-curious need doses and screening this label refuses; the yohimbe-averse are buying it blind
Skip it if…
- Anyone with blood-pressure, heart, or anxiety history — yohimbine's documented effect profile is those three things; undosed means unscreenable
- Anyone on antidepressants, stimulants, or BP medication — yohimbine's interaction list is a pharmacology chapter
- Anyone whose "Vivalis" came from Walmart — that's a different S.O LABS product sharing a name
The Evidence Rating reflects research on the finished product and/or named ingredients for the intended use. The Product Fit Score is a separate practical assessment of formula completeness, ease of use, guarantee/buying terms, price/value and category relevance. Neither score is a customer rating, and affiliate relationships do not determine either score. See the full scoring method.
What Vivalis is
Vivalis is a daily capsule at $69/$59/$49 with a consistent 60-day guarantee and a published panel — an 838 mg proprietary blend of tribulus, horny goat weed, tongkat, panax ginseng, ashwagandha, and yohimbe — with no per-ingredient doses, drifting alternate rosters on its satellite pages, an unrelated Walmart product sharing its name, and one page claiming the FDA "approved" it (no supplement is).
When disclosure identifies the hazard it doesn't manage
Our men's aisle has graded every disclosure failure mode; Vivalis adds the strangest — enough label to find the risk, not enough to size it. Yohimbine is this category's one genuinely drug-like molecule (FAQ), with the blood-pressure profile that makes our hypertension page required reading before it, and content-variability findings that make even honest labels unreliable. Inside an 838 mg six-way blend, its dose could be trivial or clinical, and neither you nor a prescriber can know which. The rest of the roster — undosed tongkat, trial-negative tribulus — is the aisle's familiar furniture around that one live wire.
| The ledger | |
|---|---|
| Panel published | Yes — names, no doses |
| Yohimbe dose | Unknown — the one number that's safety-critical |
| Alternate rosters | Drifting on satellite pages |
| Name collision | Unrelated Walmart product |
| Guarantee | 60 days, consistent |
Verdict
2.1/5 — a blend priced by its riskiest unknown. Yohimbine's real file belongs where it historically lived: dosed, prescribed, screened. Everything else this bottle promises routes to the aisle's fixed answers — the checkup, the morning blood draw, and dosed single-ingredient versions of anything that survives them.
Frequently asked questions
What is yohimbe, honestly?
Bark of an African tree whose alkaloid, yohimbine, is real medicine — an alpha-2 adrenergic antagonist studied and once widely prescribed for ED before PDE5 inhibitors, at controlled doses around 5–10 mg with medical screening. Its side-effect profile (elevated blood pressure, tachycardia, anxiety, insomnia) is why it's prescription-only in several countries, and FDA-commissioned analyses have found supplement yohimbine content ranging from trace to far above labeled amounts. Real drug, real doses, real screening — three things this blend provides none of.
Isn't publishing the panel worth more credit?
It earns the transparency points we gave — naming yohimbe is more than most funnels disclose — and naming without dosing inverts for this ingredient specifically. For maca or ginseng, a missing dose means unknown efficacy; for yohimbine, it means unknown exposure to a cardiovascular-active alkaloid. The more pharmacology an ingredient has, the more its milligrams are safety information. This label discloses exactly enough to identify the risk and not enough to manage it.
What about the other five botanicals?
The aisle's standard cast at unknown doses — tongkat (real at 200 mg, unstated here), ginseng (small ED literature), ashwagandha (stress trials at 300–600 mg), tribulus (repeatedly trial-negative for testosterone), epimedium (lab-tier). Every one is graded across our men's-health reviews; none changes the headline, because a blend is priced by its riskiest unknown, and this one's is unusual for actually mattering.
Undosed yohimbe specifically — why does it earn the queue's sharpest warning?
Because yohimbine is the rare supplement ingredient with genuine drug-strength pharmacology in both directions: a real alpha-2 antagonist with documented blood-pressure elevation, anxiety and interaction risks, prescription-regulated in several countries, and — per independent analyses of yohimbe products — wildly variable in actual content versus labels even when amounts are printed. Undosed, inside a blend, aimed at older men (the demographic most likely to carry cardiovascular disease and its medications), it converts a dubious product into an unscreenable one: neither you nor a pharmacist can bound the exposure. One roster line, properly read, ends the purchase decision before price or promises get a hearing.
Vivalis — from $69 · 60-day seller refund window
Check current price on the seller's site Compare men's health supplements
Affiliate links. Our evaluation is unaffected — the criterion scores above explain the verdict either way.
References
- NIDDK. Erectile Dysfunction (ED) (2024). https://www.niddk.nih.gov/health-information/urologic-diseases/erectile-dysfunction
- U.S. Food and Drug Administration. Dietary Supplements (2024). https://www.fda.gov/food/dietary-supplements
- Federal Trade Commission. FTC Endorsement Guides (2023). https://www.ftc.gov/business-guidance/resources/ftcs-endorsement-guides-what-people-are-asking
Low libido, erectile dysfunction and symptoms blamed on “low testosterone” can have cardiovascular, hormonal, medication-related or psychological causes. Supplements do not replace evaluation or proven treatment. Check testosterone with appropriate testing before treating a presumed deficiency, and review interaction risks with your clinician.